Related Experiment Video
Updated: Apr 15, 2026

04:28
Lung Tumor Cell Recruitment Assay
Published on: February 26, 2019
6.1K
[Cervical cancer screening: Is active recruitment worth the effort?]
Ángeles Morales Martínez1, Lorena Blanco Rodríguez1, Cristina Morales Martínez2
1Centro de Salud de Natahoyo, Gijón, España.
Atencion Primaria
|April 1, 2015
Summary
High cervical cancer screening coverage was observed in women aged 40-50. However, active recruitment of unscreened women for Pap smears and HPV testing proved ineffective in this population.
Area of Science:
- Gynecology
- Public Health
- Oncology
Background:
- Cervical cancer screening is crucial for early detection and prevention.
- Opportunistic screening programs aim to reach target populations.
- Understanding screening coverage and HPV prevalence is vital for public health strategies.
Purpose of the Study:
- To determine Pap smear coverage in women aged 40-50.
- To identify cervical cancer precursors and HPV prevalence in unscreened/inadequately screened women.
- To evaluate the effectiveness of active recruitment for cervical cancer screening.
Main Methods:
- Cross-sectional study conducted at Natahoyo Health Centre, Gijón, Spain.
- Data collected via databases, telephone, and home surveys.
- Active recruitment offered cytology and HPV testing to unscreened/inadequately screened women.
Main Results:
- 87% of 1420 women aged 40-50 had Pap smears in the last 5 years.
- 13% were unscreened or inadequately screened; 58.7% of these accepted cytology and HPV testing.
- HPV prevalence was 8.3%; no high-grade cervical dysplasia was diagnosed.
Conclusions:
- Opportunistic cervical cancer screening coverage is high in this population.
- Active recruitment strategies for cervical cancer screening were not effective.
- Further research may be needed to optimize screening program outreach.
Keywords:
Active recruitmentCaptación activaCervical cancerCitologíaCribado oportunistaCáncer de cérvixHuman papillomavirusOpportunistic screeningPap smearVirus del papiloma humanoMore Related Videos
Related Concept Videos
Cancer Vaccines
1.4K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K
Cancer Prevention
8.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.7K
Cancer Prevention
3.1K
3.1K
Mouse Models of Cancer Study
6.8K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.8K
Mouse Models of Cancer Study
2.6K
2.6K

